Patent details

EP2957292 Title: THERAPY FOR VITILIGO

Basic Information

Publication number:
EP2957292
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP151705720
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THERAPY FOR VITILIGO
French Title of Invention:
THERAPIE POUR LE VITILIGO
German Title of Invention:
VITILIGO-BEHANDLUNG
SPC Number:

Dates

Filing date:
27/03/2009
Grant date:
13/12/2017
EP Publication Date:
23/12/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/12/2017
EP B1 Publication Date:
13/12/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/03/2018
Expiration date:
27/03/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/12/2017
 
 

Name:
Clinuvel Pharmaceuticals Limited
Address:
Level 6, 15 Queen Street, Melbourne, VIC 3000, Australia (AU)

Agent

Name:
Office FREYLINGER S.A.
From:
28/12/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Wolgen, Philippe
Address:
Australia (AU)

Priority

Priority Number:
2008901461
Priority Date:
27/03/2008
Priority Country:
Australia (AU)

Classification

IPC classification:
A61K 9/00; A61K 31/37; A61K 31/436; A61K 31/485; A61K 31/505; A61K 31/52; A61K 31/573; A61K 31/58; A61K 38/13; A61K 38/21; A61K 38/34; A61K 45/06; A61N 5/06; A61P 17/00; C07K 14/685;

Publication

European Patent Bulletin

Issue number:
201750
Publication date:
13/12/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/12/2017 Power Of Attorney 1
31/07/2018 Outgoing Correspondence 1
09/01/2018 Outgoing Correspondence 1